Literature DB >> 6821928

Sensitive fluorometry of heat-stable alkaline phosphatase (Regan enzyme) activity in serum from smokers and nonsmokers.

W C Maslow, H A Muensch, F Azama, A S Schneider.   

Abstract

We developed a simple, sensitive enzymatic assay involving the fluorogenic substrate naphthol AS-MX phosphate [(3-hydroxy-2-naphthoic acid 2,4-dimethylanilide) phosphate] to measure heat-stable alkaline phosphatase (EC 3.1.3.1), the Regan isoenzyme, in human serum. The day-to-day CV was 5.7% for a serum activity of 0.080 arbitrary units/L. Measurable amounts of enzyme were detected in most normal individuals. The mean for 51 nonsmokers was 0.068 (SD 0.037) arb. units/L; for 25 smokers it was 0.440 (SD 0.360) arb. units/L. Activity of this isoenzyme in smokers was as much as 10-fold the upper normal limit for nonsmokers. Activation of this tumor marker by smoking has not received attention hitherto. We conclude that a truly normal range can only be established among nonsmokers. The isoenzymes in smokers, nonsmokers, and pregnant women were similar in their heat stability, immunologic cross reactivity, and inhibition by L-phenylalanine.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6821928

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  12 in total

1.  Profiles of epitope-defined markers in sera from patients with testicular germ cell tumors.

Authors:  H Yamamoto; U Rudén; P Esposti; K Hirano; T Stigbrand; L Andersson; H Hisazumi; B Wahren
Journal:  Urol Res       Date:  1988

2.  Serum placental type alkaline phosphatase in cigarette smokers.

Authors:  P J McLaughlin; A M Twist; C C Evans; P M Johnson
Journal:  J Clin Pathol       Date:  1984-07       Impact factor: 3.411

3.  Heat-stable alkaline phosphatase as a marker for human and monkey type-I pneumocytes.

Authors:  E J Nouwen; N Buyssens; M E De Broe
Journal:  Cell Tissue Res       Date:  1990-05       Impact factor: 5.249

4.  Serum placental-like alkaline phosphatase (PLAP): a novel combined enzyme linked immunoassay for monitoring ovarian cancer.

Authors:  J Fisken; R C Leonard; G Shaw; A Bowman; J E Roulston
Journal:  J Clin Pathol       Date:  1989-01       Impact factor: 3.411

5.  Serum placental-type alkaline phosphatase activity in women with squamous and glandular malignancies of the reproductive tract.

Authors:  T E Ind; R K Iles; P G Carter; D G Lowe; J H Shepherd; C N Hudson; T Chard
Journal:  J Clin Pathol       Date:  1994-11       Impact factor: 3.411

6.  Placental alkaline phosphatase as a tumour marker in seminoma using the H17 E2 monoclonal antibody assay.

Authors:  A Horwich; D F Tucker; M J Peckham
Journal:  Br J Cancer       Date:  1985-05       Impact factor: 7.640

7.  Placental-type alkaline phosphatase in cervical neoplasia.

Authors:  P J McLaughlin; P H Warne; G E Hutchinson; P M Johnson; D F Tucker
Journal:  Br J Cancer       Date:  1987-02       Impact factor: 7.640

8.  Serum marker potential of placental alkaline phosphatase-like activity in testicular germ cell tumours evaluated by H17E2 monoclonal antibody assay.

Authors:  D F Tucker; R T Oliver; P Travers; W F Bodmer
Journal:  Br J Cancer       Date:  1985-05       Impact factor: 7.640

9.  Detection of placental-type alkaline phosphatase in ovarian cancer.

Authors:  I W McDicken; P J McLaughlin; P M Tromans; D M Luesley; P M Johnson
Journal:  Br J Cancer       Date:  1985-07       Impact factor: 7.640

10.  Monoclonal antibody assay of serum placental alkaline phosphatase in the monitoring of testicular tumours.

Authors:  A A Epenetos; A J Munro; D F Tucker; W Gregory; W Duncan; R H MacDougall; M Faux; P Travers; W F Bodmer
Journal:  Br J Cancer       Date:  1985-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.